The Industry Innovation Partnership Program (I2P2) launched in October 2016. I2P2 provides funding to innovators from industry organizations to support testing and validation of aging and brain health solutions that are at an advanced stage of development.
CABHI assesses innovations, awards funding to successful finalists and brokers relationships between innovators and North American trial partners, creating capacity in the system and boosting economic development. Innovators obtain vital evidence to inform commercialization decisions for launching aging and brain health products and services in the Canadian marketplace. At the same time, seniors at test sites in community and institution-based settings benefit from early access to adopt promising new solutions that can improve health outcomes and quality of life.
CABHI will support eligible project costs directly associated with validating innovations and trial testing, up to $600,000 CAD per project, with total funding of $3 million CAD to be awarded over 18 months, starting in September 2017. Funding is provided directly to the host institution of qualifying projects, with up to $600,000 CAD matching contributions made by commercial partners to the project.
In our first I2P2 call, we received 47 expressions of interest from applicants in Canada, Norway, USA and Israel, and 13 were then invited to submit full applications. Successful finalists will be notified in June 2017 and projects will begin in September.